Monitor for further insider selling or potential conversion to a 13D filing if Mailman's intent shifts. The reduction in a large insider stake could signal waning confidence ahead of upcoming catalysts or financial results.
Price Chart
Executive Summary
Joshua Mailman filed an amended Schedule 13G disclosing a 9.99% passive stake in Jaguar Health, Inc. as of September 12, 2026. The filing indicates a decrease from a prior higher position, with total beneficial ownership of 189,617 shares. This reduction signals reduced conviction by a notable insider.
Key Financial Metrics
Key Facts
- Joshua Mailman reported beneficial ownership of 189,617 shares of Jaguar Health common stock.
- The stake represents 9.99% of shares outstanding as of September 12, 2026.
- The filing is an amendment to Schedule 13G, indicating a change from a prior filing.
- The filing certifies passive intent under Rule 13d-1(c), not activist intent.
Financial Impact
Reduction in insider stake from a prior higher level; current stake valued at approximately $189,617 based on par value, but actual market value depends on current price.
Risk Factors
- Insider selling may continue, pressuring the stock.
- The company's small market cap and low liquidity could amplify the impact of any further stake reductions.
- Passive certification limits Mailman's ability to engage in activist activities without converting to 13D.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001185185-26-004289 |
| Document: 0001185185-26-004289-index.html | 0001185185-26-004289 |
| Document: 0001185185-26-004289.txt | 0001185185-26-004289 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | S-3 | $2.04 | awaiting T+60 | — | $2.24 (−9.80%) |
Oct 8, 2026 19d ago | DEF 14A | $4.79 | awaiting T+60 | — | $2.24 (+53.24%) |
Oct 5, 2026 22d ago | 8-K | $4.73 | awaiting T+60 | — | $2.24 (+52.64%) |
Sep 28, 2026 29d ago | 8-K | $6.02 | awaiting T+60 | — | $2.24 (+62.79%) |
Sep 24, 2026 4w ago | SC 13G/A | $7.70 | awaiting T+60 | — | $2.24 (+70.91%) |
Sep 24, 2026 4w ago | 424B5 | $7.06 | awaiting T+60 | — | $2.24 (+68.27%) |
Sep 24, 2026 4w ago | 8-K | $7.06 | awaiting T+60 | — | $2.24 (+68.27%) |
Sep 21, 2026 5w ago | 8-K | $34.46 | awaiting T+60 | — | $2.24 (−93.50%) |
Sep 15, 2026 6w ago | 8-K | $0.2246 | awaiting T+60 | — | $2.24 (−897.33%) |
Sep 3, 2026 7w ago | 424B5 | $10.41 | awaiting T+60 | — | $2.24 (+78.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers